← Every company
BioLife Solutions Inc SEC Filings
What BioLife Solutions Inc has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.
BLFS overview →Filings on file
157
since Oct 6, 2016
Warning signs
9
latest Oct 6, 2026
Last results
Aug 6, 2026
8-K item 2.02
Industry
Electromedical & Electrotherapeutic Apparatus
SIC 3845
Newest first
Each label is a form type or an 8-K item as filed; each row links to the filing.
| Filed | What it reports | Document |
|---|---|---|
| Oct 6, 2026 | Delisting notice or listing transferExecutive or director changeAcquisition or sale completedChange in controlShareholder vote 8-K | Read ↗ |
| May 11, 2023 | Late filing notice NT 10-Q | Read ↗ |
| Mar 17, 2023 | Late filing notice NT 10-K | Read ↗ |
| Apr 7, 2022 | Auditor change 8-K | Read ↗ |
| Mar 18, 2022 | Delisting notice or listing transfer 8-K | Read ↗ |
| Mar 2, 2022 | Late filing notice NT 10-K | Read ↗ |
| Apr 30, 2020 | Late filing notice NT 10-K | Read ↗ |
| Apr 30, 2020 | Earlier accounts withdrawn 8-K | Read ↗ |
| Dec 17, 2019 | Auditor change 8-K | Read ↗ |
Source: BioLife Solutions Inc's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.